The potential of PCNA inhibition as a therapeutic strategy in cervical cancer-Reference-Cited by-同舟云学术

The potential of PCNA inhibition as a therapeutic strategy in cervical cancer

Published:2023-11 Issue:11 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Wendel Sebastian O.¹,Snow Jazmine A.¹,Gu Long²,Banerjee Nilam Sanjib³,Malkas Linda²,Wallace Nicholas A.¹^ORCID

Affiliation:

1. Division of Biology Kansas State University Manhattan Kansas USA

2. Beckman Research Institute of City of Hope Duarte California USA

3. Department of Biochemistry and Molecular Genetics University of Alabama at Birmingham Birmingham Alabama USA

Abstract

AbstractCervical cancers are the fourth most common and most deadly cancer in women worldwide. Despite being a tremendous public health burden, few novel approaches to improve care for these malignancies have been introduced. We discuss the potential for proliferating cell nuclear antigen (PCNA) inhibition to address this need as well as the advantages and disadvantages for compounds that can therapeutically inhibit PCNA with a specific focus on cervical cancer.

Funder

National Institutes of Health

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29244

Reference81 articles.

1. The Papillomavirus Episteme: a major update to the papillomavirus sequence database

2. WHO.Human papillomavirus (HPV) and cervical cancer.2016.https://www.who.int/mediacentre/factsheets/fs380/en/

3. HPV infection and cervical disease: A review

4. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases

5. Cervical cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The bacterial DNA sliding clamp, β-clamp: structure, interactions, dynamics and drug discovery;Cellular and Molecular Life Sciences;2024-05-30

2. Integrin α_vβ₃-targeted self-assembled polypeptide nanomicelles for efficacious sonodynamic therapy against breast cancer;Nanoscale;2024

3. Anti-filarial efficacy of Centratherum anthelminticum: unravelling the underlying mechanisms through biochemical, HRAMS proteomics and MD simulation approaches;RSC Advances;2024